Collecting health data and samples from people with autoimmune diseases
Follows adults with rheumatoid arthritis, lupus or systemic sclerosis, plus healthy volunteers.
Plain-language title generated from the registry record
Registry title: Immun4Cure Cohort of Autoimmune Diseases
Key facts
- Where
- Montpellier, FranceSee the site
Where in France
- CHU de Montpellier - CIMAMontpellier, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Montpellier
- Trial code
- NCT07515638
- Record updated
- 30 June 2026
- Original description
This prospective cohort study aims to constitute a 500-participant database and biobank including 450 adults with systemic autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis) and 50 healthy controls.Read full original descriptionShow less
Prospective Cohort Study of Clinical and Biological Data in Patients With Autoimmune Diseases (Immun4Cure Cohort)
This prospective cohort study aims to constitute a 500-participant database and biobank including 450 adults with systemic autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis) and 50 healthy controls.
Inclusion: Group 1: RA; Adults ≥18 years; Patient followed as part of their MAI in one of the departments participating in the study at UHM; Confirmed diagnosis according to international criteria :ACR/EULAR 2010; Group 2: LES; Adults ≥18 years; Patient followed as part of their MAI in one of the departments participating in the study at UHM; Confirmed diagnosis according to international criteria :ACR/EULAR 2019; Group 3: SSc; Adults ≥18 years; Patient followed as part of their MAI in one of the departments participating in the study at UHM; Confirmed diagnosis according to international criteria :ACR/EULAR 2013; Group 4: Healthy Controls; Adults ≥18 years; No symptoms of autoimmune disease; No first-degree family history of autoimmune disease.
Exclusion: Patients who have refused or are unable to give informed consent; Inability to follow the subject during the study period; Participation in another interventional study that includes an exclusion period that is still ongoing; Pregnant women; Not affiliated with a social security scheme; Patients without a national insurance number; Persons under judicial protection, guardianship or trusteeship; Persons deprived of their liberty.